News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
147,350 Results
Type
Article (14386)
Company Profile (10)
Press Release (132954)
Section
Business (39815)
Career Advice (209)
Deals (5374)
Drug Delivery (16)
Drug Development (18657)
Employer Resources (25)
FDA (2897)
Job Trends (3208)
News (66095)
Policy (5381)
Tag
Academia (1701)
Accelerated approval (1)
Adcomms (11)
Allergies (14)
Alliances (12659)
ALS (21)
Alzheimer's disease (484)
Antibody-drug conjugate (ADC) (21)
Approvals (2906)
Artificial intelligence (69)
Autoimmune disease (1)
Automation (3)
Bankruptcy (32)
Best Places to Work (2746)
BIOSECURE Act (14)
Biosimilars (8)
Biotechnology (6)
Bladder cancer (24)
Brain cancer (9)
Breast cancer (80)
Cancer (664)
Cardiovascular disease (33)
Career advice (195)
Career pathing (4)
CAR-T (43)
Cell therapy (102)
Cervical cancer (10)
Clinical research (14428)
Collaboration (209)
Compensation (12)
Complete response letters (2)
COVID-19 (1046)
CRISPR (12)
C-suite (57)
Cystic fibrosis (22)
Data (507)
Depression (4)
Diabetes (36)
Diagnostics (1641)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (27)
Drug pricing (19)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (9098)
Editorial (9)
Employer branding (3)
Employer resources (20)
Events (18829)
Executive appointments (152)
FDA (3151)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (277)
Gene editing (21)
Generative AI (2)
Gene therapy (92)
GLP-1 (106)
Government (1163)
Guidances (12)
Healthcare (4861)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (12)
Indications (3)
Infectious disease (1081)
Inflammatory bowel disease (33)
Inflation Reduction Act (2)
Influenza (8)
Intellectual property (13)
Interviews (20)
IPO (2742)
IRA (12)
Job creations (552)
Job search strategy (185)
Kidney cancer (6)
Labor market (8)
Layoffs (48)
Leadership (1)
Legal (932)
Liver cancer (22)
Lung cancer (105)
Lymphoma (46)
Machine learning (3)
Management (6)
Manufacturing (54)
MASH (10)
Medical device (2424)
Medtech (2424)
Mergers & acquisitions (2771)
Metabolic disorders (65)
Multiple sclerosis (18)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (596)
NextGen: Class of 2025 (1613)
Non-profit (1873)
Now hiring (5)
Obesity (21)
Opinion (46)
Ovarian cancer (26)
Pain (20)
Pancreatic cancer (18)
Parkinson's disease (32)
Partnered (5)
Patents (31)
Patient recruitment (29)
Peanut (9)
People (15303)
Pharmaceutical (6)
Phase I (4866)
Phase II (6629)
Phase III (4387)
Pipeline (231)
Policy (47)
Postmarket research (567)
Preclinical (2234)
Press Release (18)
Prostate cancer (26)
Psychedelics (10)
Radiopharmaceuticals (47)
Rare diseases (77)
Real estate (1212)
Recruiting (11)
Regulatory (3701)
Reports (9)
Research institute (1867)
Resumes & cover letters (17)
Rett syndrome (1)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (41)
Series B (17)
Sickle cell disease (19)
Spinal muscular atrophy (23)
Sponsored (1)
Startups (1068)
Stomach cancer (3)
Supply chain (15)
Tariffs (4)
Vaccines (217)
Venture capitalists (11)
Weight loss (9)
Women's health (3)
Worklife (3)
Date
Last 7 days (170)
Last 30 days (519)
Last 365 days (6678)
2025 (2134)
2024 (7240)
2023 (8735)
2022 (11600)
2021 (12973)
2020 (12254)
2019 (10990)
2018 (8145)
2017 (7445)
2016 (7485)
2015 (8761)
2014 (6510)
2013 (5385)
2012 (5476)
2011 (5675)
2010 (4874)
Location
Africa (193)
Alabama (33)
Alaska (3)
Arizona (51)
Arkansas (3)
Asia (9238)
Australia (2056)
California (1096)
Canada (352)
China (75)
Colorado (52)
Connecticut (48)
Delaware (40)
Europe (19581)
Florida (218)
Georgia (21)
Idaho (11)
Illinois (122)
India (6)
Indiana (44)
Iowa (1)
Japan (46)
Kansas (21)
Kentucky (11)
Louisiana (1)
Maine (9)
Maryland (163)
Massachusetts (789)
Michigan (28)
Minnesota (66)
Missouri (25)
Montana (6)
Nebraska (4)
Nevada (4)
New Hampshire (12)
New Jersey (489)
New Mexico (6)
New York (392)
North Carolina (157)
North Dakota (3)
Northern California (467)
Ohio (47)
Oklahoma (5)
Oregon (8)
Pennsylvania (244)
Puerto Rico (1)
Rhode Island (7)
South America (263)
South Carolina (5)
Southern California (416)
Tennessee (21)
Texas (240)
United States (4605)
Utah (34)
Virginia (32)
Washington D.C. (34)
Washington State (127)
West Virginia (1)
Wisconsin (10)
147,350 Results for "institut pasteur".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation
February 26, 2025
·
5 min read
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology
May 29, 2024
·
3 min read
Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years
Sensorion announces that the research partnership framework agreement signed in 2019 with the Institut Pasteur granting Sensorion an option for exclusive licenses to develop and market gene therapy drug candidates from collaborative projects to address unmet medical needs in the hearing field has been extended for a period of five years.
January 5, 2024
·
8 min read
Galectin Therapeutics to Present Data on Liver Cirrhosis at the 9th Edition of the Paris NASH meeting, at Institut Pasteur, September 7th & 8th 2023
Galectin Therapeutics Inc. (NASDAQ: GALT) announced today the Company will participate in the 9th Edition of the Paris NASH meeting, where a select group of international experts gather each year at the prestigious Institut Pasteur in Paris to discuss the latest scientific and clinical research developments in non-alcoholic steatohepatitis (NASH) and its complications, including liver cirrhosis.
September 7, 2023
·
5 min read
Standigm and Institut Pasteur Korea Identify Drug Candidates for Resistant Tuberculosis Thanks to Right Foundation Grant
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB).
April 4, 2023
·
5 min read
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
April 28, 2025
·
2 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Press Releases
Cybin to Participate at the 28th Annual Milken Institute Global Conference
May 1, 2025
·
5 min read
Business
Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies
Satio, Inc today announced a strategic partnership agreement with Institut Pasteur de Dakar.
August 23, 2022
·
2 min read
Press Releases
ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor
April 8, 2025
·
5 min read
1 of 14,735
Next
